Hepatitis C screening and management practices: A survey of drug treatment and syringe exchange programs in New York City

American Journal of Public Health

Volumn 92, Issue 8, 2002, Pages 1254-1256

  Udeagu Pratt, Chi Chi N ^a   Paone, Denise ^a   Carter, Rosalind J ^a   Layton, Marcelle C ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COCAINE; DIAMORPHINE; HEPATITIS C ANTIBODY; ILLICIT DRUG; INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; HEALTH CARE FINANCING; HEALTH INSURANCE; HEALTH PROGRAM; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MASS SCREENING; NURSE; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICIAN; QUESTIONNAIRE; SOCIAL WORKER; SYRINGE; UNITED STATES;

EID: 0036311610     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/ajph.92.8.1254     Document Type: Article

References (17)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
2. Hepatitis C
3. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
4. The importance of preventing hepatitis C virus infection among injection drug users in the United States
5. Hepatitis C, II: Prevention counseling and medical evaluation
6. Chronic hepatitis C: Early intervention
7. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
8. Reduced risk of hepatitis B and hepatitis C among injection drug users in Tacoma syringe exchange program
9. Methadone treatment and HIV and hepatitis C risk reduction among injectors in the Seattle area
10. Syringe exchange and risk of infection with hepatitis B and C viruses
11. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program
12. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors
13. Hepatitis C: Diagnosis, prevention, and control
14. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin
15. Cost-effectiveness of screening patients for hepatitis C
16. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: Results of the National Hepatitis Screening Survey
17. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users